Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Benzoyl peroxide 2.5% cream
1306010C0AAAZAZ
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 2.5% gel
1306010C0AAAAAA
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 5% / Erythromycin 3% gel
1306010C0AAAYAY
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 5% cream
1306010C0AAADAD
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 5% lotion
1306010C0AAAHAH
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 5%/Potassium hydroxyquin sulf 0.5% crm
1306010C0AAAUAU
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzyl benzoate crystals
1310040C0AAADAD
|
Benzyl benzoate | Benzyl benzoate | Skin | No data available |
|
Bepro 6.75mg/5ml syrup
0407020C0BBAABA
|
Bepro | Codeine phosphate | Central Nervous System | No data available |
|
Berinert 1,500unit inj vials
0304030F0BDACAE
|
Berinert | C1-Esterase inhibitor | Respiratory System | No data available |
|
Berlind 75 Retard capsules
1001010K0BXAAAD
|
Berlind | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Berocca Boost effervescent tablets sugar free
090602800BBJIA0
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Berocca effervescent tablets blackcurrant
090602800BBJNCZ
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Berocca effervescent tablets mango
090602800BBJLCZ
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Berocca effervescent tablets mixed berries
090602800BBJJCZ
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Berocca effervescent tablets tropical
090602800BBJKCZ
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Berocca tablets
091000000BBWRBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Berodual N inhaler
0301040M0BCABAD
|
Berodual | Fenoterol hydrobromide | Respiratory System | No data available |
|
Berotec 200micrograms/dose inhaler
0301011F0BBACAA
|
Berotec | Fenoterol hydrobromide | Respiratory System | No data available |
|
Besponsa 1mg pdr for concentrate for inf
0801050CEBBAAAA
|
Besponsa | Inotuzumab | Malignant Disease and Immunosuppression | No data available |
|
Besremi 250micrograms/0.5ml inj pre-filled pens
0802040BCBBAAAA
|
Besremi | Ropeginterferon alfa | Malignant Disease and Immunosuppression | No data available |
|
Beta two piece ostomy system bag
23945859401
|
Beta two piece ostomy system bag | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Beta two piece ostomy system kit
23945859400
|
Beta two piece ostomy system kit | Two Piece Ostomy Systems | Stoma Appliances | No data available |
|
Beta-Adalat modified-release capsules
0204000U0BBAAAA
|
Beta-Adalat | Atenolol with calcium channel blocker | Cardiovascular System | No data available |
|
Beta-Cardone 200mg tablets
0204000T0BBACAF
|
Beta-Cardone | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Beta-Cardone 40mg tablets
0204000T0BBAAAB
|
Beta-Cardone | Sotalol hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.